Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain

被引:0
|
作者
Perez-Rubio, Alberto [1 ]
Mestre-Ferrandiz, Jorge [2 ]
Lopez-Belmonte, Juan Luis [3 ]
Diaz-Aguilo, Ariadna [4 ]
Lorenzo-Herrero, Seila [5 ]
Crespo, Carlos [6 ,7 ]
机构
[1] Complejo Asistencial Avila, Med Direct, Avila, Spain
[2] Carlos III Univ, Madrid, Spain
[3] Sanofi, Market Access, Madrid, Spain
[4] Sanofi, Market Access, Barcelona, Spain
[5] Axent Solut, Oviedo, Spain
[6] Axent Solut, Barcelona, Spain
[7] Univ Barcelona, Barcelona, Spain
关键词
Burden; DALY; Infectious diseases; Immunization; Vaccines; DOSE INFLUENZA VACCINE; GLOBAL BURDEN; EPIDEMIOLOGY; EFFICACY;
D O I
10.1186/s12879-024-09637-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundThe objective of this study is to estimate the burden of selected immunization-preventable infectious diseases in Spain using the Burden of Communicable Diseases in Europe (BCoDE) methodology, as well as focusing on the national immunization programme and potential new inclusions. MethodsThe BCoDE methodology relies on an incidence and pathogen-based approach to calculate disease burden via disability-adjusted life year (DALY) estimates. It considers short and long-term sequelae associated to an infection via outcome trees. The BCoDE toolkit was used to populate those trees with Spanish-specific incidence estimates, and de novo outcome trees were developed for four infections (herpes zoster, rotavirus, respiratory syncytial virus [RSV], and varicella) not covered by the toolkit. Age/sex specific incidences were estimated based on data from the Spanish Network of Epidemiological Surveillance; hospitalisation and mortality rates were collected from the Minimum Basic Data Set. A literature review was performed to design the de novo models and obtain the rest of the parameters. The methodology, assumptions, data inputs and results were validated by a group of experts in epidemiology and disease modelling, immunization and public health policy. ResultsThe total burden of disease amounted to 163.54 annual DALYs/100,000 population. Among the selected twelve diseases, respiratory infections represented around 90% of the total burden. Influenza exhibited the highest burden, with 110.00 DALYs/100,000 population, followed by invasive pneumococcal disease and RSV, with 25.20 and 10.57 DALYs/100,000 population, respectively. Herpes zoster, invasive meningococcal disease, invasive Haemophilus influenza infection and hepatitis B virus infection ranked lower with fewer than 10 DALYs/100,000 population each, while the rest of the infections had a limited burden (< 1 DALY/100,000 population). A higher burden of disease was observed in the elderly (>= 60 years) and children < 5 years, with influenza being the main cause. In infants < 1 year, RSV represented the greatest burden. ConclusionsAligned with the BCoDE study, the results of this analysis show a persisting high burden of immunization-preventable respiratory infections in Spain and, for the first time, highlight a high number of DALYs due to RSV. These estimates provide a basis to guide prevention strategies and make public health decisions to prioritise interventions and allocate healthcare resources in Spain.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Time to disable DALYs?On the use of disability-adjusted life-years in health policy
    Carl Hampus Lyttkens
    [J]. The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (3): : 195 - 202
  • [2] Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020
    Singh, Balbir B.
    Devleesschauwer, Brecht
    Khatkar, Mehar S.
    Lowerison, Mark
    Singh, Baljit
    Dhand, Navneet K.
    Barkema, Herman W.
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020
    Balbir B. Singh
    Brecht Devleesschauwer
    Mehar S. Khatkar
    Mark Lowerison
    Baljit Singh
    Navneet K. Dhand
    Herman W. Barkema
    [J]. Scientific Reports, 12
  • [4] Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review
    Daniel Teshome Gebeyehu
    Leah East
    Stuart Wark
    Md Shahidul Islam
    [J]. BMC Public Health, 23
  • [5] Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review
    Gebeyehu, Daniel Teshome
    East, Leah
    Wark, Stuart
    Islam, Md Shahidul
    [J]. BMC PUBLIC HEALTH, 2023, 23 (01)
  • [6] The national burden of cerebrovascular diseases in Spain: A population-based study using disability-adjusted life years
    Catala-Lopez, Ferran
    Fernandez de Larrea-Baz, Nerea
    Morant-Ginestar, Consuelo
    Alvarez-Martin, Elena
    Diaz-Guzman, Jaime
    Genova-Maleras, Ricard
    [J]. MEDICINA CLINICA, 2015, 144 (08): : 353 - 359
  • [7] Estimating Disability-Adjusted Life Years (DALYs) in Community Cases of Norovirus in England
    Harris, John P.
    Iturriza-Gomara, Miren
    O'Brien, Sarah J.
    [J]. VIRUSES-BASEL, 2019, 11 (02):
  • [8] Current and future Disability-Adjusted Life Years (DALYs) of Salmonella and Campylobacter in Belgium
    Charline Maertens de Noordhout
    Brecht Devleesschauwer
    Diallo Lamarana
    Juanita Haagsma
    Arie Havelaar
    Sophie Quoilin
    Sophie Bertrand
    Yves Dupont
    Olivier Vandenberg
    Patrick Brandt
    Niko Speybroeck
    [J]. Archives of Public Health, 73 (Suppl 1)
  • [9] Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: A systematic review protocol
    Gebeyehu, Daniel Teshome
    East, Leah
    Wark, Stuart
    Islam, Md Shahidul
    [J]. PLOS ONE, 2022, 17 (09):
  • [10] Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis In Iran, 2013
    Heydarpour, Fatemeh
    Sari, Ali Akbari
    Mohebali, Mehdi
    Shirzadi, Mohammadreza
    Bokaie, Saied
    [J]. ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2016, 26 (04) : 381 - 388